Featured Insights
September 21, 2026
Client Alert
Dompé’s $32 million settlement with DOJ (following a voluntary self-disclosure) offers important lessons to pharmaceutical manufactures and underscores the government’s heightened focus on manufacturer relationships with patient assistance foundations.
September 21, 2026
Podcast
CMS proposed the RAPID pathway to fast-track Medicare coverage for breakthrough medical devices. The Latham team explores how the pathway works and what it means for device manufacturers.
September 18, 2026
Client Alert
The Risk Alert highlights the staff’s ongoing focus on advisers’ Rule 206(4)-7 annual compliance reviews and identifies recurring issues observed during recent examinations.